0.5599
price down icon0.81%   -0.0047
 
loading
Scilex Holding Company stock is traded at $0.5599, with a volume of 887.63K. It is down -0.81% in the last 24 hours and down -42.86% over the past month. Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
See More
Previous Close:
$0.5646
Open:
$0.58
24h Volume:
887.63K
Relative Volume:
0.48
Market Cap:
$75.61M
Revenue:
$46.74M
Net Income/Loss:
$-114.33M
P/E Ratio:
-0.9313
EPS:
-0.6012
Net Cash Flow:
$-21.04M
1W Performance:
-17.65%
1M Performance:
-42.86%
6M Performance:
-49.55%
1Y Performance:
-40.90%
1-Day Range:
Value
$0.5539
$0.5831
1-Week Range:
Value
$0.5377
$0.7348
52-Week Range:
Value
$0.5377
$2.63

Scilex Holding Company Stock (SCLX) Company Profile

Name
Name
Scilex Holding Company
Name
Phone
(650) 516-4310
Name
Address
960 SAN ANTONIO ROAD, PALO ALTO
Name
Employee
113
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
SCLX's Discussions on Twitter

Compare SCLX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SCLX 0.56 75.61M 46.74M -114.33M -21.04M -0.6012
LLY 749.72 703.88B 40.86B 8.37B -2.28B 5.4193
NVO 102.92 467.74B 39.36B 13.79B 9.83B 2.4077
JNJ 155.54 353.35B 87.70B 14.68B 19.03B 13.47
ABBV 172.00 296.46B 55.53B 5.12B 15.62B 3.65
MRK 99.23 248.23B 63.17B 12.15B 14.84B 1.80

Scilex Holding Company Stock (SCLX) Latest News

pulisher
Nov 18, 2024

Open Text Corp (OTEX-Q) QuotePress Release - The Globe and Mail

Nov 18, 2024
pulisher
Nov 15, 2024

Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 1419, 2024 - The Manila Times

Nov 15, 2024
pulisher
Nov 15, 2024

Scilex Holding Company Announces Presentation of Data at - GlobeNewswire

Nov 15, 2024
pulisher
Nov 15, 2024

Scilex Holding Company Announces Presentation of Data at the 2024 American College of ... - The Bakersfield Californian

Nov 15, 2024
pulisher
Nov 15, 2024

Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024 - Yahoo Finance

Nov 15, 2024
pulisher
Nov 12, 2024

Private companies who have a significant stake must be disappointed along with institutions after Scilex Holding Company's (NASDAQ:SCLX) market cap dropped by US$22m - Simply Wall St

Nov 12, 2024
pulisher
Nov 07, 2024

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Pre - The Manila Times

Nov 07, 2024
pulisher
Nov 06, 2024

Scilex Holding Plans Merger to Boost Semnur Value - TipRanks

Nov 06, 2024
pulisher
Nov 06, 2024

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of - GlobeNewswire

Nov 06, 2024
pulisher
Nov 06, 2024

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces - The Bakersfield Californian

Nov 06, 2024
pulisher
Nov 06, 2024

Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary - Barchart

Nov 06, 2024
pulisher
Nov 02, 2024

Boeing Company (BA-N) QuotePress Release - The Globe and Mail

Nov 02, 2024
pulisher
Oct 31, 2024

Chipotle Mexican Grill (CMG-N) QuotePress Release - The Globe and Mail

Oct 31, 2024
pulisher
Oct 31, 2024

Scilex Pharmaceuticals announces end of phase II meeting with FDA for SP-103 - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail

Oct 31, 2024
pulisher
Oct 30, 2024

Scilex holding's CEO Jaisim Shah buys $31,670 worth of shares - Investing.com India

Oct 30, 2024
pulisher
Oct 30, 2024

A W Food Services of Canada Inc (AW-T) QuotePress Release - The Globe and Mail

Oct 30, 2024
pulisher
Oct 30, 2024

Pleasing Signs As A Number Of Insiders Buy Scilex Holding Stock - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of - GlobeNewswire

Oct 30, 2024
pulisher
Oct 29, 2024

Scilex holding's CEO Jaisim Shah buys $31,670 worth of shares By Investing.com - Investing.com Canada

Oct 29, 2024
pulisher
Oct 29, 2024

Jaisim Shah Acquires 32,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Scilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock - ForexTV.com

Oct 29, 2024
pulisher
Oct 29, 2024

Scilex Holding Company, Following its Prior Announcement of - GlobeNewswire

Oct 29, 2024
pulisher
Oct 28, 2024

Scilex Holding Sets Dividend for Preferred Stock Exchange - TipRanks

Oct 28, 2024
pulisher
Oct 28, 2024

Scilex Holding Company sets November 7, 2024 as the Record - GlobeNewswire

Oct 28, 2024
pulisher
Oct 20, 2024

Alliance Global Partners Begins Coverage on Scilex (NASDAQ:SCLX) - Defense World

Oct 20, 2024
pulisher
Oct 19, 2024

Scilex gains on spinoff plans for pharma subsidiary - MSN

Oct 19, 2024
pulisher
Oct 19, 2024

Scilex director Followwill Dorman buys $990 in common stock By Investing.com - Investing.com South Africa

Oct 19, 2024
pulisher
Oct 19, 2024

Scilex director Followwill Dorman buys $990 in common stock - Investing.com

Oct 19, 2024
pulisher
Oct 19, 2024

Scilex director Chun Jay acquires $4,750 in common stock - Investing.com

Oct 19, 2024
pulisher
Oct 18, 2024

Holding Company Shares Rally Following Board Of Directors Commentary - MSN

Oct 18, 2024
pulisher
Oct 18, 2024

Scilex Holding (NASDAQ:SCLX) Director Yue Alexander Wu Acquires 20,000 Shares - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Scilex holding's executive chairperson Ji Henry buys $9,710 in stock - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Scilex director Wu Yue Alexander buys $18,992 in common stock By Investing.com - Investing.com South Africa

Oct 18, 2024
pulisher
Oct 18, 2024

Scilex director Wu Yue Alexander buys $18,992 in common stock - Investing.com India

Oct 18, 2024
pulisher
Oct 18, 2024

Scilex holding's executive chairperson Ji Henry buys $9,710 in stock By Investing.com - Investing.com UK

Oct 18, 2024
pulisher
Oct 18, 2024

Scilex director Chun Jay acquires $4,750 in common stock By Investing.com - Investing.com Australia

Oct 18, 2024
pulisher
Oct 18, 2024

Scilex CFO Stephen Hoi purchases $6,499 in common stock - Investing.com India

Oct 18, 2024
pulisher
Oct 17, 2024

Scilex Holding's CEO Jaisim Shah purchases $29,751 in common stock - Investing.com India

Oct 17, 2024
pulisher
Oct 17, 2024

Scilex Holding's CEO Jaisim Shah purchases $29,751 in common stock By Investing.com - Investing.com Canada

Oct 17, 2024
pulisher
Oct 17, 2024

Jaisim Shah Purchases 30,000 Shares of Scilex Holding (NASDAQ:SCLX) Stock - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Scilex CFO Stephen Hoi purchases $6,499 in common stock By Investing.com - Investing.com UK

Oct 17, 2024
pulisher
Oct 16, 2024

Scilex Explores Strategic Options, Analyst Initiates On Blockbuster Potential For Sciatica Pain Candidate - Benzinga

Oct 16, 2024
pulisher
Oct 16, 2024

TSX Energy Capped Index (TTEN) QuotePress Release - The Globe and Mail

Oct 16, 2024
pulisher
Oct 16, 2024

Scilex Holding looks to separate Scilex Pharma through potential spinout, IPO - FiercePharma

Oct 16, 2024
pulisher
Oct 16, 2024

Scilex stock gains on spinoff plans (SCLX:NASDAQ) - Seeking Alpha

Oct 16, 2024
pulisher
Oct 16, 2024

Scilex Holding explores spinoff for subsidiary Scilex Pharma - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Scilex Holding Company Announces that its Board of Directors has Authorized Management to Explore Ways to Maximize the Value of its Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., including by way of conducting a spinoff or public listing of securit - The Manila Times

Oct 16, 2024
pulisher
Oct 16, 2024

Scilex Holding explores spinoff for subsidiary Scilex Pharma By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

Scilex Holding Company Announces that its Board of - GlobeNewswire

Oct 16, 2024

Scilex Holding Company Stock (SCLX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_general BMY
$58.09
price up icon 0.40%
drug_manufacturers_general SNY
$47.95
price up icon 0.37%
drug_manufacturers_general PFE
$25.12
price up icon 0.72%
$290.00
price up icon 0.60%
drug_manufacturers_general NVS
$103.85
price up icon 0.72%
drug_manufacturers_general MRK
$99.47
price up icon 2.05%
Cap:     |  Volume (24h):